Smith & Nephew completed the acquisition of substantially all the assets of Healthpoint Biotherapeutics.
Smith & Nephew closes $782 million Healthpoint deal
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.